Events
Newsletter
Partner With Us
Contact
Sign In
Subscribe
Home
>
Superficial Venous Disease
Debate: C2 Disease Should Not Be A Covered Insurance Benefit
Categories
Clinical Cases
Controversies
Deep Venous Disease
Diagnostics
Expert Discussion
Hemodynamics
Superficial Venous Disease
Thromboembolic Disease
Venous and Lymphatics
Venous Practice
Industry Content
Debate: C2 Disease Should Not Be A Covered Insurance Benefit
Related Videos
View
2022 Varicose Vein Guidelines
Peter Gloviczki, MD, FACS
Lecture
1 Like
View
Thermal Devices: RF And Laser: Which When
Thomas Proebstle, MD, PhD
Lecture
1 Like
View
Foam: Proprietary Polidocanol Microfoam Or Physician Compounded
Edward G. Mackay, MD, FACS, RPVI, RVT
Lecture
1 Like
View
Ambulatory Phlebectomy Technical Pearls
Paul McNeill, MD
Lecture
1 Like
View
Complications I've Seen From Superficial Vein Procedures
Lowell S. Kabnick, MD, RPhS, FACS, FACPh
Lecture
1 Like
View
Vein Global - Superficial Vein Theater
Peter Gloviczki, MD, FACS; Lowell S. Kabnick, MD, RPhS, FACS, FACPh; Edward G. Mackay, MD, FACS, RPVI, RVT; Nick Morrison, MD, FACS, FACPh, RPhS; Paul McNeill, MD
Panel Discussion
1 Like
View
C1 Disease: What Work Up Is Needed
Edward G. Mackay, MD, FACS, RPVI, RVT
Lecture
1 Like
View
Sclerotherapy, Laser Or Both
Kandy Hammond, RN, BSN, MBA/HCM
Lecture
1 Like
View
Complications of Sclerotherapy
Edward G. Mackay, MD, FACS, RPVI, RVT
Lecture
1 Like
View
Using Cyanoacrylate Safely
Kathleen D. Gibson, MD
Lecture
1 Like
View
Saphenous Ablation: How To
Jose I. Almeida, MD, FACS, RPVI, RVT
Lecture
1 Like
View
Important RCTs for Thermal Ablation
Peter Gloviczki, MD, FACS
Lecture
1 Like